Skip to main content

Currently Skimming:

Message from the Co-Chairs
Pages 2-3

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 2...
... The Forum membership also continued its focused effort to address challenges in the drug discovery and development process by facilitating an action-oriented collaborative that identified ratelimiting steps and facilitated dialogue for potential process improvement efforts in the biomedical innovation ecosystem. The Forum also supported and fostered cross-disciplinary dialogue through workshops focusing on genetic bioresources for drug discovery and seamless cancer-focused drug development.
From page 3...
... In addition to continuing action collaborative work on responsible sharing of clinical trial data and harmonization of clinical trial site standards, the Forum will launch new action collaboratives in 2017 focused on addressing the barriers and opportunities to improving the drug development process and on furthering the science of patient input. The Forum will also convene a workshop exploring enabling precision medicine through genetics in clinical drug development.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.